Chemical Composition and Carcinogenicity of Smokeless Tobacco

Abstract

In the United States, smokeless tobacco (ST) is marketed as chewing tobacco and as oral snuff. During the past 15 years, consumption of chewing tobacco has declined by 30.6%, whereas snuff use has significantly increased, namely, by 51.8%. This increase is primarily due to the growing popularity of oral snuff use among teenage and young adolescent males. Chewing of tobacco is associated with an increased risk for oral cancer. Snuff dipping is causally and specifically associated with cancer of the cheek, gum, and pharynx. In laboratory animals, snuff induces cancer of the mouth. Several carcinogens have been identified in ST, the tobacco-specific N-nitrosamine (TSNA), N'-nitrosonornicotine (NNN), and 4(methylnitrosamino)-l-(3-pyridyl)-l-butanone (NNK) being the most important. NNN and NNK are formed from nicotine during curing, aging, and especially during fermentation of tobacco. Oral swabbing of a low concentration of a mixture of NNN plus NNK in water induces oral tumors in rats. The concentration of the strongly carcinogenic TSNA is higher in snuff than in other ST products. According to our analytical studies, the three leading snuff brands in the US (92% of the market) contain far higher concentrations of nicotine, unprotonated nicotine, and TSNA than the less popular brands. Thus, the leading US snuff brands are the strongest inducers of nicotine dependence and also have the highest carcinogenic potential.

Keywords

Bioassay carcinogenicity oral neoplasms smokeless tobacco snuff tobacco-specific N-nitrosamines.

Get full access to this article

View all access options for this article.

References

Andersson G. , Axell T. (1989). Clinical appearance of lesions associated with the use of loose and portion-bag packed Swedish moist snuff. A comparative study. J Oral Pathol Med 18:2-7.

Armitage AK , Turner DM (1970). Absorption of nicotine in cigarette and cigar smoke through the oral mucosa. Nature 226:1231-1232.

Benowitz NL (1991). Nicotine and coronary heart disease. Trends Cardiovasc Med 1:315-321.

Benowitz NL , Jacob P. III , Yu L. (1989). Daily use of smokeless tobacco: systemic effects . Ann Intern Med 111:112-116.

Bruerd B. (1990). Smokeless tobacco use among native American school children. Publ Hlth Rep 105:196-201.

Brunnemann KD , Hoffmann D. (1974). The pH of tobacco smoke. Food Cosmet Toxicol 12:115-124.

Brunnemann KD , Hoffmann D. (1992). Chemical composition of smokeless tobacco products . Smoking and Tobacco Control Monogr. Vol. 2. National Cancer Institute, pp. 96-108.

Carmella SG , Kagan SS , Kagan M. , Foiles PG , Palladino G. , Quart E. , et al. (1990). Mass spectrometric analysis of tobacco-specific nitrosamine hemoglobin adducts in snuff dippers, smokers, and nonsmokers. Cancer Res 50 :5438-5445.

Connolly GN (1995). The marketing of nicotine addiction by one oral snuff manufacturer. Tobacco Control 4:73-79.

10.

Creek L. , Capehart T. , Grise V. (1994). Tobacco statistics 1935-1992. US Dept. of Agriculture . Stat Bull 869:299.

11.

Djordjevic MV , Hoffmann D. , Glynn T. , Connolly GN (1995). US commercial brands of moist snuff, 1994. I. Assessment of nicotine, moisture, and pH. Tobacco Control 4:62-66.

12.

Hecht SS , Rivenson A. , Braley J. , DiBello J. , Adams JD , Hoffmann D. (1986). Induction of oral cavity tumors in F344 rats by tobacco-specific N-nitrosamines and snuff. Cancer Res 46:4162-4166.

13.

Hecht SS , Haley NJ , Hoffmann D. (1991). Monitoring exposure to tobacco products by measurement of nicotine metabolites and derived carcinogens. In: Molecular dosimetry and human cancer: analytical, epidemio-logical, and social considerations . Groopmann JD , Skipper PL , editors. Boca Raton, FL: CRC Press, pp. 325-361.

14.

Henningfield JE , Radzins A. , Cone EJ ( 1995). Estimation of available nicotine content of six smokeless tobacco products. Tobacco Control 4:57-61.

15.

Hirsch J-M. , Thilander H. (1981). Snuff-induced lesions of the oral mucosa: an experimental model in the rat. J Oral Pathol 10:342-353.

16.

Hoffmann D. , Adams JD (1981). A study of tobacco carcinogenesis. XXIII. Carcinogenic tobacco-specific N-nitrosamines in snuff and in the saliva of snuff dippers . Cancer Res 41:4305-4308.

17.

Hoffmann D. , Rivenson A. , Hecht SS (1992). Carcinogenesis of smokeless tobacco. In: Smokeless tobacco or health: An international perspective. National Cancer Institute, Smoking & Tobacco Control Monogr. 2. NIH Publ. No. 92-3461, Sept., pp. 109-118.

18.

Hoffmann D. , Brunnemann KD , Prokopczyk B. , Djordjevic MV (1994). Tobacco-specific N-nitrosamines and areca-derived N-nitrosamines: chemistry, biochemistry, carcinogenicity, and relevance to humans. J Toxicol Environ Hlth 41:1-52.

19.

Hoffmann D. , Djordjevic MV , Fan J. , Zang E. , Glynn T. , Connolly GN (1995). Five leading US commercial brands of moist snuff in 1994: assessment of carcinogenic N-nitrosamines. J Natl Cancer Inst 87:1862-1869.

20.

Johansson SL , Hirsch JM , Larsson PA , Saidi J. , Oesterdahl BG (1989). Snuff-induced carcinogenesis: effect of snuff in rats initiated with 4-nitroquinoline-N-oxide. Cancer Res 49:3063-3069.

21.

Murphy SE , Carmella SG , Idris AM , Hoffmann D. (1994). Uptake and metabolism of carcinogenic levels of tobacco-specific nitrosamines by Sudanese snuff dippers. Cancer Epidemiol Biomarkers Prev 3:423-428.

22.

Orlandi MA , Boyd G. ( 1989). Smokeless tobacco use among adolescents; a theoretical overview. Natl Cancer Inst Monogr 8:5-12.

23.

Palladino G. , Adams JD , Brunnemann KD , Haley NJ , Hoffmann D. (1986). Snuff dipping in college students: a clinical profile. Military Med 151:342-346.

24.

Park N-H. , Sapp JP , Herbosa EG (1986). Oral cancer induced in hamsters with herpes simplex infection and simulated snuff dipping. Oral Surg Oral Med Oral Pathol 62 :164-168.

25.

Peterson JS , Barreto LA , Brunnemann KD (1990). Smokeless tobacco: a product of the new generation of tobacco users. Dipping and chewing in the Northwest Territories, Canada, and its global relevance. Arctic Med Res 2(Suppl 49):32-38.

26.

Spitz MR , Fueger JJ , Goepfert H. , Hong WK , Newell GR (1988). Squamous cell carcinoma of the upper aero-digestive tract. A case comparison analysis. Cancer 61:203-208.

27.

Tomar SC , Giovino GA , Eriksen MP (1995). Smokeless tobacco brand preference and brand switching among US adolescents and young adults. Tobacco Control 4:67-72.

28.

US Department of Agriculture (1995). Statistical summary. Tobacco Sit Ser 233:13-16.

29.

US Surgeon General (1964). Smoking and health. US Department of Health, Education and Welfare . PHS Publ. No. 1103, p. 387.

30.

US Surgeon General (1986). The health consequences of using smokeless tobacco. US Department of Health and Human Services. NIH Publ. No. 86-2874, p. 195.

31.

US Surgeon General (1988). The health consequences of smoking. Nicotine addiction. US Department of Health and Human Services. DHHS Publ. No. (CDC) 88-8406, p. 639.

32.

Winn DM , Blot WJ , Shy CM , Pickle LW , Toledo A. , Fraumeni JF (1981). Snuff dipping and oral cancer among women in the southern United States. New Engl J Med 304:745-749.

33.

Wray A. , McGuirt WF (1993). Smokeless tobacco usage associated with oral carcinoma. Incidence, treatment, outcome. Arch Otolaryngol Head Neck Surg 119:929-933.